BC Technology4h
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug ...
BC Technology5h
Photonic Accelerates Timeline to 'Useful Quantum Computing' With Industry First Breakthrough Results in Error Correction
In an industry first, Photonic Inc. announced that it has introduced a new, low-overhead family of Quantum Low-Density Parity Check (QLDPC) codes that can efficiently perform both quantum computation ...
BC Technology5h
Zymeworks Announces $50 Million Private Placement with EcoR1 Capital, Proceeds Expected to Extend Cash Runway Into H2 2027
Zymeworks Inc., a clinical-stage biopharmaceutical company developing novel, multifunctional biotherapeutics, announced that it has entered into a securities purchase agreement with funds affiliated ...
BC Technology5h
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Lexaria Bioscience Corp., a global innovator in drug delivery platforms, provided progress updates on its Phase 1b, 12-week ...
BC Technology1d
Invinity Energy Systems Announces Release of Next-Gen Modular Vanadium Flow Battery ENDURIUM to Transform Grid-Scale Energy Storage
Invinity Energy Systems has announced the commercial release of ENDURIUM, their next-generation modular vanadium flow battery. ENDURIUM builds on the company's experience of three generations of flow ...
BC Technology1d
Vancouver-based Early-Stage VC Firm GTMfund Raises $79 Million (US $54 Million) Second Fund
GTMfund announced that it has raised an oversubscribed Fund II of $78.83 million (US $54 million). GTMfund is an early-stage ...
BC Technology2d
XLYNX Materials Reports Breakthrough in Direct Photopatterning of Quantum Dots Using Diazirine-Based Crosslinkers
XLYNX Materials announced a pioneering breakthrough in the direct photopatterning of colloidal quantum dots (QDs), addressing long-standing challenges in resolution, scalability, and material ...
BC Technology2d
Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial, Announces Validcare’s $250K Equity Investment
Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...
BC Technology3d
Notch Therapeutics Takes Steps to Preserve Cash and Explore Alternative Paths Forward' After Raising U.S. $85M Series-A Financing 3 Years Ago
Vancouver, BC, February 10, 2025-- (T-Net)-- Notch Therapeutics issued a statement recently indicating that the company is taking steps to preserve cash and explore alternative paths forward after ...
BC Technology3d
WELL Health Technologies Provides Corporate Update on Financial Performance of its Acquired Canadian Clinics
WELL Health Technologies Corp., a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, ...
BC Technology3d
Vecima Announces Preliminary Second Quarter Fiscal 2025 Results
Vecima Networks Inc. announced that its second quarter financial results will reflect impacts related to adjustments in the timing of some of its largest customers' cable and fiber upgrades, as well ...
BC Technology3d
Government of Canada Launches 'Canadian Genomics Strategy' With $175 Million in Federal Funding Over Seven Years
The Government of Canada announced the launch of the Canadian Genomics Strategy, which is backed by an investment of $175.1 million in federal funding over seven years, starting in 2024-25. The ...